US 10722523
Chemoimmunotherapy for epithelial cancer
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10722523 (Chemoimmunotherapy for epithelial cancer) held by The Regents of the University of California expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2300/00, A61K31/136